Does RUXOLITINIB Cause Splenomegaly? 1,995 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,995 reports of Splenomegaly have been filed in association with RUXOLITINIB (OPZELURA). This represents 2.9% of all adverse event reports for RUXOLITINIB.
1,995
Reports of Splenomegaly with RUXOLITINIB
2.9%
of all RUXOLITINIB reports
292
Deaths
686
Hospitalizations
How Dangerous Is Splenomegaly From RUXOLITINIB?
Of the 1,995 reports, 292 (14.6%) resulted in death, 686 (34.4%) required hospitalization, and 55 (2.8%) were considered life-threatening.
Is Splenomegaly Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RUXOLITINIB. However, 1,995 reports have been filed with the FAERS database.
What Other Side Effects Does RUXOLITINIB Cause?
Off label use (12,492)
Death (6,561)
Fatigue (5,663)
Anaemia (3,593)
Haemoglobin decreased (3,297)
Platelet count decreased (3,028)
Diarrhoea (2,531)
Asthenia (2,529)
Dizziness (2,398)
Pneumonia (2,343)
What Other Drugs Cause Splenomegaly?
RITUXIMAB (326)
PREDNISONE (299)
IBRUTINIB (279)
CYCLOPHOSPHAMIDE (254)
METHOTREXATE (253)
OXALIPLATIN (253)
ADALIMUMAB (245)
TACROLIMUS (218)
IMATINIB (216)
VENETOCLAX (211)
Which RUXOLITINIB Alternatives Have Lower Splenomegaly Risk?
RUXOLITINIB vs SABRIL
RUXOLITINIB vs SACCHAROMYCES CEREVISIAE
RUXOLITINIB vs SACITUZUMAB GOVITECAN
RUXOLITINIB vs SACITUZUMAB GOVITECAN-HZIY
RUXOLITINIB vs SACROSIDASE